CHAIN aims to build value for our stakeholders while delivering positive societal impacts in a sustainable, ethical and principled manner.
CHAIN works with academic and industrial partners that can support gut-microbiome target discovery and CADDTM platform expansion. We have a track record in obtaining grant awards to support collaborative research projects.
CHAIN also seeks licensing partners from the healthcare and pharmaceutical industries for our lead asset CHN-1 which delivers a potent anti-inflammatory to the gut targeting inflammatory bowel disease.
Building a team of experts:
At CHAIN, we are building a team of expert scientists and business specialists to develop the company into a global healthcare leader specialising in diseases related to the human microbiome. We seek talented individuals who value hard work and creativity and share our vision.
As our novel biotherapeutics progress towards the clinic, we are keen to hear from interested candidates with clinical trial expertise. Expertise in the human microbiome, immunology, synthetic biology, and regulatory affairs are also desirable. In addition, we are interested in experts who can help shape and manage the drug development process in our business operations.
CHAIN is committed to promoting equal opportunities in employment. The company offers a competitive compensation and benefits package. If you are interested in working for CHAIN, please contact email@example.com